Mimedx (MDXG) Depreciation and Depletion (2011 - 2026)
Mimedx (MDXG) reported Depreciation and Depletion of $528000.0 for Q1 2026, down 5.38% on a YoY basis from $558000.0 in Q1 2025, and down 7.69% sequentially from $572000.0 in Q4 2025.
Mimedx (MDXG) Depreciation and Depletion (2011 - 2026) Analysis & Trends
Mimedx (MDXG) has 16 years of Depreciation and Depletion data on file, last reported at $528000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 5.38% year-over-year to $528000.0; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 1.33% YoY), and the FY2025 full-year result was $2.3 million, down 0.66% from the prior year.
- Depreciation and Depletion slipped to $528000.0 in Q1 2026, from $572000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $860000.0 in Q1 2022 to a low of $528000.0 in Q1 2026.
- A 5-year average of $650470.6 and a median of $580000.0 in 2024 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion plunged 34.3% in 2022 and increased 1.42% in 2025, its largest moves.
- Tracing MDXG's Depreciation and Depletion over 5 years: stood at $796000.0 in 2022, then slipped by 23.24% to $611000.0 in 2023, then fell by 7.69% to $564000.0 in 2024, then advanced by 1.42% to $572000.0 in 2025, then fell by 7.69% to $528000.0 in 2026.
- Business Quant data shows MDXG's Depreciation and Depletion at $528000.0 in Q1 2026, $572000.0 in Q4 2025, and $572000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | 528,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 528,000.00 |
| Mar 31, 2026 | 528,000.00 |
| Dec 31, 2025 | 572,000.00 |
| Dec 31, 2025 | 572,000.00 |
| Sep 30, 2025 | 572,000.00 |
| Sep 30, 2025 | 572,000.00 |
| Jun 30, 2025 | 558,000.00 |
| Jun 30, 2025 | 558,000.00 |
| Mar 31, 2025 | 558,000.00 |
| Mar 31, 2025 | 558,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Jun 30, 2024 | 558,000.00 |
| Jun 30, 2024 | 558,000.00 |
| Mar 31, 2024 | 558,000.00 |
| Mar 31, 2024 | 558,000.00 |
| Dec 31, 2023 | 611,000.00 |
| Dec 31, 2023 | 611,000.00 |